サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：単純ヘルペス角膜炎治療の世界市場（2022年～2028年）：薬剤別、投与経路別、地域別の市場規模調査と予測
市場調査レポート
商品コード
1105723

単純ヘルペス角膜炎治療の世界市場（2022年～2028年）：薬剤別、投与経路別、地域別の市場規模調査と予測

Global Herpes Simplex Keratitis Treatment Market Size study, By Drug (Famciclovir, Valacyclovir, Acyclovir, Other Drugs), By Route of Administration (Topical, Injection, Oral), and Regional Forecasts 2022-2028
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
単純ヘルペス角膜炎治療の世界市場（2022年～2028年）：薬剤別、投与経路別、地域別の市場規模調査と予測
出版日: 2022年07月12日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の単純ヘルペス角膜炎治療の市場規模は、2022年～2028年の予測期間中に健全な成長率で拡大すると予想されています。

市場を牽引する主な要因には、単純ヘルペス角膜炎の発生件数の増加、医薬品分野における研究支出の増加、規制当局からの最近の承認などがあります。

当レポートは、世界の単純ヘルペス角膜炎治療市場を調査し、市場の概要、市場の促進要因・抑制要因の分析、市場機会、COVID-19の影響、セグメント別の市場分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の単純ヘルペス角膜炎治療市場：定義と範囲

第3章 世界の単純ヘルペス角膜炎治療：市場力学

  • 単純ヘルペス角膜炎治療市場：影響分析（2020年～2028年）

第4章 世界の単純ヘルペス角膜炎治療市場：業界分析

  • ポーターのファイブフォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論
  • 主要な投資機会
  • 主要な成功戦略

第5章 リスク評価：COVID-19の影響

    • 業界に対するCOVID-19の全体的な影響の評価
    • COVID-19以前およびCOVID-19後の市場シナリオ

第6章 世界の単純ヘルペス角膜炎治療市場：薬剤別

  • 市場のスナップショット
  • 実績：潜在的な分析
  • 市場規模の推計と予測（2018年～2028年）
  • サブセグメント分析
    • ファムシクロビル
    • バラシクロビル
    • アシクロビル
    • その他

第7章 世界の単純ヘルペス角膜炎治療市場：投与経路別

  • 市場のスナップショット
  • 実績：潜在的な分析
  • 市場規模の推計と予測（2018年～2028年）
  • サブセグメント分析
    • 局所
    • 注射
    • 経口

第8章 世界の単純ヘルペス角膜炎治療市場：地域分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州のスナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋地域のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカのスナップショット
    • ブラジル
    • メキシコ
  • 世界のその他の地域

第9章 競合情勢

  • 主な市場戦略
  • 企業プロファイル
    • GlaxoSmithKline
    • Vectans Pharma
    • Blistex
    • Bausch Health
    • Aurobindo Pharma
    • Dr. Reddy's Laboratories
    • Cipla
    • Jubilant Cadista
    • Mylan
    • Emcure Pharmaceuticals Ltd

第10章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Herpes Simplex Keratitis Treatment Market, report scope
  • TABLE 2. Global Herpes Simplex Keratitis Treatment Market estimates & forecasts by Region 2018-2028 (USD Million)
  • TABLE 3. Global Herpes Simplex Keratitis Treatment Market estimates & forecasts by Drug 2018-2028 (USD Million)
  • TABLE 4. Global Herpes Simplex Keratitis Treatment Market estimates & forecasts by Route of Administration 2018-2028 (USD Million)
  • TABLE 5. Global Herpes Simplex Keratitis Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 6. Global Herpes Simplex Keratitis Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 7. Global Herpes Simplex Keratitis Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 8. Global Herpes Simplex Keratitis Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 9. Global Herpes Simplex Keratitis Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 10. Global Herpes Simplex Keratitis Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 11. Global Herpes Simplex Keratitis Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 12. Global Herpes Simplex Keratitis Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 13. Global Herpes Simplex Keratitis Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 14. Global Herpes Simplex Keratitis Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 15. U.S. Herpes Simplex Keratitis Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 16. U.S. Herpes Simplex Keratitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 17. U.S. Herpes Simplex Keratitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 18. Canada Herpes Simplex Keratitis Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 19. Canada Herpes Simplex Keratitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 20. Canada Herpes Simplex Keratitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 21. UK Herpes Simplex Keratitis Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 22. UK Herpes Simplex Keratitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 23. UK Herpes Simplex Keratitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 24. Germany Herpes Simplex Keratitis Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 25. Germany Herpes Simplex Keratitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 26. Germany Herpes Simplex Keratitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 27. RoE Herpes Simplex Keratitis Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 28. RoE Herpes Simplex Keratitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 29. RoE Herpes Simplex Keratitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 30. China Herpes Simplex Keratitis Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 31. China Herpes Simplex Keratitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 32. China Herpes Simplex Keratitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 33. India Herpes Simplex Keratitis Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 34. India Herpes Simplex Keratitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 35. India Herpes Simplex Keratitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 36. Japan Herpes Simplex Keratitis Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 37. Japan Herpes Simplex Keratitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 38. Japan Herpes Simplex Keratitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 39. RoAPAC Herpes Simplex Keratitis Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 40. RoAPAC Herpes Simplex Keratitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 41. RoAPAC Herpes Simplex Keratitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 42. Brazil Herpes Simplex Keratitis Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 43. Brazil Herpes Simplex Keratitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 44. Brazil Herpes Simplex Keratitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 45. Mexico Herpes Simplex Keratitis Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 46. Mexico Herpes Simplex Keratitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 47. Mexico Herpes Simplex Keratitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 48. RoLA Herpes Simplex Keratitis Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 49. RoLA Herpes Simplex Keratitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 50. RoLA Herpes Simplex Keratitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 51. Row Herpes Simplex Keratitis Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 52. Row Herpes Simplex Keratitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 53. Row Herpes Simplex Keratitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 54. List of secondary sources, used in the study of global Herpes Simplex Keratitis Treatment Market
  • TABLE 55. List of primary sources, used in the study of global Herpes Simplex Keratitis Treatment Market
  • TABLE 56. Years considered for the study
  • TABLE 57. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Herpes Simplex Keratitis Treatment Market, research methodology
  • FIG 2. Global Herpes Simplex Keratitis Treatment Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Herpes Simplex Keratitis Treatment Market, key trends 2021
  • FIG 5. Global Herpes Simplex Keratitis Treatment Market, growth prospects 2022-2028
  • FIG 6. Global Herpes Simplex Keratitis Treatment Market, porters 5 force model
  • FIG 7. Global Herpes Simplex Keratitis Treatment Market, pest analysis
  • FIG 8. Global Herpes Simplex Keratitis Treatment Market, value chain analysis
  • FIG 9. Global Herpes Simplex Keratitis Treatment Market by segment, 2018 & 2028 (USD Million)
  • FIG 10. Global Herpes Simplex Keratitis Treatment Market by segment, 2018 & 2028 (USD Million)
  • FIG 11. Global Herpes Simplex Keratitis Treatment Market by segment, 2018 & 2028 (USD Million)
  • FIG 12. Global Herpes Simplex Keratitis Treatment Market by segment, 2018 & 2028 (USD Million)
  • FIG 13. Global Herpes Simplex Keratitis Treatment Market by segment, 2018 & 2028 (USD Million)
  • FIG 14. Global Herpes Simplex Keratitis Treatment Market, regional snapshot 2018 & 2028
  • FIG 15. North America Herpes Simplex Keratitis Treatment Market 2018 & 2028 (USD Million)
  • FIG 16. Europe Herpes Simplex Keratitis Treatment Market 2018 & 2028 (USD Million)
  • FIG 17. Asia pacific Market 2018 & 2028 (USD Million)
  • FIG 18. Latin America Herpes Simplex Keratitis Treatment Market 2018 & 2028 (USD Million)
  • FIG 19. Global Herpes Simplex Keratitis Treatment Market, company Market share analysis (2021)
目次

Global Herpes Simplex Keratitis Treatment Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. The Herpes Simplex Keratitis disease can be defined as infection of the cornea. It is caused by recurrent infection of the cornea by herpes simplex virus (HSV). The virus is mostly transmitted by droplet transmission, and by direct inoculation. Herpes keratitis is one of the leading infectious causes of corneal ulcers and blindness worldwide. HSV infection usually heals without damaging the eye, but severe infections can lead to scarring of the cornea or blindness. The growing incidences of Herpes Simplex Keratitis and increasing research spending in pharmaceuticals sector as well as recent approvals from regulatory authorities are factors that are accelerating the global market demand. For instance, according to American Academy of ophthalmology (AAO)- as of 2020, the global prevalence of HSV keratitis was estimated 1.5 million yearly. Around 40,000 new cases result in severe visual impairment. In the United States, approximately 500,000 people diagnosed with ocular HSV. Furthermore, recent product approvals regulatory authorities would influence the growth of Herpes Simplex Keratitis Treatment Market. For instance, in September 2021, Hyderabad, India based Aurobindo Pharma received Indian patent for antiviral drug valacyclovir from the Indian Patent Office. This drug is sold in US and other countries under the trade name Valtrex. Also, growing healthcare infrastructure in emerging economies and increasing prevalence of infectious diseases are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, high treatment cost associated with Herpes Simplex Keratitis impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Herpes Simplex Keratitis Treatment market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growing incidences of infections associated with the herpes simplex virus and presence of leading market players in the region. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as growing pharmaceuticals sector and recent approvals from regulatory authorities in the region, would create lucrative growth prospects for the Herpes Simplex Keratitis Treatment market across the Asia Pacific region.

Major market players included in this report are:

GlaxoSmithKline

Vectans Pharma

Blistex

Bausch Health

Aurobindo Pharma

Dr. Reddy's Laboratories

Cipla

Jubilant Cadista

Mylan

Emcure Pharmaceuticals Ltd

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug:

Famciclovir

Valacyclovir

Acyclovir

Other Drugs

By Route of Administration:

Topical

Injection

Oral

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Herpes Simplex Keratitis Treatment Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
    • 1.2.1. Global Herpes Simplex Keratitis Treatment Market, by Region, 2020-2028 (USD Million)
    • 1.2.2. Global Herpes Simplex Keratitis Treatment Market, by Drug, 2020-2028 (USD Million)
    • 1.2.3. Global Herpes Simplex Keratitis Treatment Market, by Route of Administration, 2020-2028 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Herpes Simplex Keratitis Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Herpes Simplex Keratitis Treatment Market Dynamics

  • 3.1. Herpes Simplex Keratitis Treatment Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing incidences of Herpes Simplex Keratitis.
      • 3.1.1.2. Increasing research spending in pharmaceuticals sector.
      • 3.1.1.3. Recent approvals from regulatory authorities.
    • 3.1.2. Market Challenges
      • 3.1.2.1. High treatment cost associated with Herpes Simplex Keratitis
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing healthcare infrastructure in emerging economies.
      • 3.1.3.2. Increasing prevalence of infectious diseases.

Chapter 4. Global Herpes Simplex Keratitis Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Herpes Simplex Keratitis Treatment Market, by Drug

  • 6.1. Market Snapshot
  • 6.2. Global Herpes Simplex Keratitis Treatment Market by Drug, Performance - Potential Analysis
  • 6.3. Global Herpes Simplex Keratitis Treatment Market Estimates & Forecasts by Drug 2018-2028 (USD Million)
  • 6.4. Herpes Simplex Keratitis Treatment Market, Sub Segment Analysis
    • 6.4.1. Famciclovir
    • 6.4.2. Valacyclovir
    • 6.4.3. Acyclovir
    • 6.4.4. Other Drugs

Chapter 7. Global Herpes Simplex Keratitis Treatment Market, by Route of Administration

  • 7.1. Market Snapshot
  • 7.2. Global Herpes Simplex Keratitis Treatment Market by Route of Administration, Performance - Potential Analysis
  • 7.3. Global Herpes Simplex Keratitis Treatment Market Estimates & Forecasts by Route of Administration 2018-2028 (USD Million)
  • 7.4. Herpes Simplex Keratitis Treatment Market, Sub Segment Analysis
    • 7.4.1. Topical
    • 7.4.2. Injection
    • 7.4.3. Oral

Chapter 8. Global Herpes Simplex Keratitis Treatment Market, Regional Analysis

  • 8.1. Herpes Simplex Keratitis Treatment Market, Regional Market Snapshot
  • 8.2. North America Herpes Simplex Keratitis Treatment Market
    • 8.2.1. U.S. Herpes Simplex Keratitis Treatment Market
      • 8.2.1.1. Drug estimates & forecasts, 2018-2028
      • 8.2.1.2. Route of Administration estimates & forecasts, 2018-2028
    • 8.2.2. Canada Herpes Simplex Keratitis Treatment Market
  • 8.3. Europe Herpes Simplex Keratitis Treatment Market Snapshot
    • 8.3.1. U.K. Herpes Simplex Keratitis Treatment Market
    • 8.3.2. Germany Herpes Simplex Keratitis Treatment Market
    • 8.3.3. France Herpes Simplex Keratitis Treatment Market
    • 8.3.4. Spain Herpes Simplex Keratitis Treatment Market
    • 8.3.5. Italy Herpes Simplex Keratitis Treatment Market
    • 8.3.6. Rest of Europe Herpes Simplex Keratitis Treatment Market
  • 8.4. Asia-Pacific Herpes Simplex Keratitis Treatment Market Snapshot
    • 8.4.1. China Herpes Simplex Keratitis Treatment Market
    • 8.4.2. India Herpes Simplex Keratitis Treatment Market
    • 8.4.3. Japan Herpes Simplex Keratitis Treatment Market
    • 8.4.4. Australia Herpes Simplex Keratitis Treatment Market
    • 8.4.5. South Korea Herpes Simplex Keratitis Treatment Market
    • 8.4.6. Rest of Asia Pacific Herpes Simplex Keratitis Treatment Market
  • 8.5. Latin America Herpes Simplex Keratitis Treatment Market Snapshot
    • 8.5.1. Brazil Herpes Simplex Keratitis Treatment Market
    • 8.5.2. Mexico Herpes Simplex Keratitis Treatment Market
  • 8.6. Rest of The World Herpes Simplex Keratitis Treatment Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. GlaxoSmithKline
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Vectans Pharma
    • 9.2.3. Blistex
    • 9.2.4. Bausch Health
    • 9.2.5. Aurobindo Pharma
    • 9.2.6. Dr. Reddy's Laboratories
    • 9.2.7. Cipla
    • 9.2.8. Jubilant Cadista
    • 9.2.9. Mylan
    • 9.2.10. Emcure Pharmaceuticals Ltd

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption